"Groundbreaking New Treatment Can Halt Progression Of Cornea Disease" - Sheila Dougherty
If we're lucky, the worst trouble most of us will have with our eyes can be remedied with glasses or contacts. But eyes are delicate parts of our anatomy, and problems that require deeper intervention aren't uncommon. In one such condition, keratoconus, the cornea - the clear front layer of the eye - progressively thins out, causing distortion of vision. It can ultimately lead to scarring and blindness. In February, Mount Sinai Health System's Eye and Ear Infirmary started using corneal collagen cross-linking to stop the progression of keratoconus. It's a minimally invasive procedure that uses ultraviolet light and a type of Vitamin B to shore up chemical bonds in the cornea. Emily C. Waisbren, MD, assistant professor of ophthalmology at the Icahn School of Medicine at Mount Sinai said, "The success of the procedure is measured by the lack of progression or by the stability of the patient's vision and refractive error."
- Emily C. Waisbren, MD, Assistant Professor, Ophthalmology, Icahn School of Medicine at Mount Sinai
Learn more
Blinding Eye Disease Strongly Associated With Serious Forms of Cardiovascular Disease
Nov 17, 2022 View All Press Releases
High-Tech Imaging Offers New Way to Detect Signs of Early Glaucoma
Aug 02, 2022 View All Press Releases
Blinding Eye Disease Is Strongly Associated With Heart Disease and Stroke
Jul 12, 2022 View All Press Releases